Market Research Logo

Continuous Renal Replacement Therapy Market Global Industry Analysis and Opportunity Assessment 2017–2027

Continuous Renal Replacement Therapy Market Global Industry Analysis and Opportunity Assessment 2017–2027

The global continuous renal replacement therapy market is poised to grow from almost US$ 743 Mn in 2016 to about US$ 1,656 Mn by 2027 end. This represents a CAGR of 7.7% during the forecast period. Several factors are responsible for this growth. Three key market drivers are highlighted below.

Product innovation and a wide product portfolio drives market growth

Strong global demand driven by an increasing dialysis patient population and rise in cases of acute kidney injuries creates synergies and broader market opportunities. Fresenius Medical Care AG & Co. KGaA, the world’s largest provider of dialysis products and services, has launched multi-FiltratePRO, a therapy system for continuous renal replacement therapy (CRRT), for the treatment of acute kidney failure in critically ill patients at intensive care units. Core positions in home hemodialysis and CRRT provide a platform for sustainable growth and investing to capitalize on the potential of next $1B+ businesses in home HD and acute care.

High prevalence of Chronic Kidney disease (CKD) worldwide

Chronic Kidney Disease (CKD) is a major risk multiplier for cardiovascular disease, diabetes, hypertension, and inflammatory disease of the kidney (glomerulonephritis). CKD may lead to kidney injury and sometimes to complete loss of kidney function, thus necessitating renal replacement therapy. World Kidney Day, a global awareness campaign estimated that 10% of the worldwide population is affected by CKD. CKD stood 18th in the global list of causes of total number of deaths in 2010 according to Global Burden Study. CKD leads to end stage renal disease (ESRD) if untreated. According to the National Kidney Foundation, about 468,000 ESRD patients were on dialysis in the U.S. in 2015. Dialysis being the most easily available treatment for kidney disease coupled with a high global prevalence of CKD are major factors driving the dialysis equipment market.

Entry of Multi-functional Continuous Renal Replacement Therapy and changes in the healthcare industry could drive up revenue growth of the market

In conventional dialysis systems every parameter is set manually and controlled by the user or caregiver. Technological advancements in currently available continuous renal replacement machines allow the management of disease parameters automatically. Most of the problems are directly handled by the automated digital machines, which is otherwise not possible in conventional systems, thus reducing the labour cost. Manufacturers are focussing on developing fully automated, portable and technologically sound dialysis equipment to provide better and vast options for users of all ages. Several measures have been taken to improve the efficiency of continuous renal replacement therapy devices, including the introduction and use of high-flux and high-efficiency membranes, which has been possible due to technological advances in polymer chemistry and membrane development.

Healthcare laws and regulations may affect market growth adversely

Healthcare companies are susceptible to a changing regulatory environment and are subject to a number of laws and regulations, non-compliance with which could adversely affect their business. The impact of healthcare laws on companies is direct to the extent companies are subject to these laws and regulations; and indirect in that in a number of situations, even though the company may not be directly regulated by specific healthcare laws and regulations, the company’s products must be capable of being used by customers in a manner that complies with those laws and regulations. The complexity of healthcare laws may have an adverse impact on the revenue growth of the global continuous renal replacement therapy market.North America is projected to dominate the global Continuous Renal Replacement Therapy (CRRT) Market in revenue terms in 2017 and this trend will continue into the next 10 years. The North America market is the most attractive region, recording an attractiveness index of 1.8 during the forecast period. North America is estimated to account for 26.0% value share in the CRRT market in 2017. However, the North America CRRT market is predicted to lose 8 BPS in its market share by 2027 over 2017, owing to efforts taken by the government and CRRT equipment manufacturers to expand dialysis products and services to other emerging regions of the globe. Western Europe is expected to be the second most lucrative region in the global CRRT market, with an attractiveness index of 1.5 during the forecast period. Western Europe is likely to hold 20.7% value share in the CRRT market in 2017.


1.Executive Summary
2.Market Introduction
2.1. Market Definition
2.2. Market Taxonomy
3.Global Continuous Renal Replacement therapy Analysis Scenario
3.1. Market Volume Analysis
3.1.1. Product Type Volume Analysis By Region
3.2. Pricing Analysis
3.2.1. Pricing Assumptions
3.2.2. Price Projections Per Region
3.3. Market Size (US$ Mn) and Forecast
3.3.1. Market Size and Y-o-Y Growth
3.3.2. Absolute $ Opportunity
3.4. Market Overview
3.4.1. Value Chain
3.4.2. Market Scenario Forecast
4.Market Dynamics
4.1. Macro-economic Factors
4.2. Drivers
4.2.1. Supply Side
4.2.2. Demand Side
4.3. Restraints
4.4. Opportunity
4.5. Trends
5. Global Continuous Renal Replacement therapy Analysis and Forecasts, By Product Type
5.1. Introduction
5.2. Basis Point Share (BPS) Analysis By Product Type
5.3. Y-o-Y Growth Projections By Product Type
5.4. Market Value Forecast By Product Type, 2017–2027
5.4.1. Dialysis System
5.4.2. Consumables
5.4.2.1. Hemofilter sets
5.4.2.2. Solution
5.4.2.3. Accessories
5.5. Market Attractiveness By Product Type
6. Global Continuous Renal Replacement therapy Analysis and Forecasts, By End User
6.1. Introduction
6.2. Basis Point Share (BPS) Analysis By End User
6.3. Y-o-Y Growth Projections By End User
6.4. Market Value Forecast By End User, 2017–2027
6.4.1. Hospital
6.4.2. Dialysis Center
6.5. Market Attractiveness By End User
7. Global Continuous Renal Replacement therapy Analysis and Forecasts, By Region
7.1. Basis Point Share (BPS) Analysis By Region
7.2. Y-o-Y Growth Projections By Region
7.3. Market Value Forecast By Region
7.3.1. North America
7.3.2. Latin America
7.3.3. Western Europe
7.3.4. Eastern Europe
7.3.5. Asia Pacific Excluding Japan (APEJ)
7.3.6. Japan
7.3.7. Middle East and Africa (MEA)
7.4. Market Attractiveness By Region
8. North America Continuous Renal Replacement therapy Analysis and Forecast
8.1. Introduction
8.1.1. Basis Point Share (BPS) Analysis By Country
8.1.2. Y-o-Y Growth Projections By Country
8.2. Market Value Forecast By Product Type, 2017–2027
8.2.1. Dialysis System
8.2.2. Consumables
8.2.2.1. Hemofilter sets
8.2.2.2. Solution
8.2.2.3. Accessories
8.3. Market Value Forecast By End User, 2017–2027
8.3.1. Hospital
8.3.2. Dialysis Center
8.4. Market Value Forecast By Country, 2017–2027
8.4.1. U.S.
8.4.2. Canada
8.5. Market Attractiveness Analysis
8.5.1. By Product Type
8.5.2. By End User
8.5.3. By Country
9. Latin America Continuous Renal Replacement therapy Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis By Country
9.1.2. Y-o-Y Growth Projections By Country
9.2. Market Value Forecast By Product Type, 2017–2027
9.2.1. Dialysis System
9.2.2. Consumables
9.2.2.1. Hemofilter sets
9.2.2.2. Solution
9.2.2.3. Accessories
9.3. Market Value Forecast By End User, 2017–2027
9.3.1. Hospital
9.3.2. Dialysis Center
9.4. Market Value Forecast By Country, 2017–2027
9.4.1. Brazil
9.4.2. Mexico
9.4.3. Rest of Latin America
9.5. Market Attractiveness Analysis
9.5.1. By Product Type
9.5.2. By End User
9.5.3. By Country
10. Western Europe Continuous Renal Replacement therapy Analysis and Forecast
10.1.Introduction
10.1.1. Basis Point Share (BPS) Analysis By Country
10.1.2. Y-o-Y Growth Projections By Country
10.2.Market Value Forecast By Product Type, 2017–2027
10.2.1. Dialysis System
10.2.2. Consumables
10.2.2.1. Hemofilter sets
10.2.2.2. Solution
10.2.2.3. Accessories
10.3.Market Value Forecast By End User, 2017–2027
10.3.1. Hospital
10.3.2. Dialysis Center
10.4.Market Value Forecast By Country, 2017–2027
10.4.1. U.K.
10.4.2. France
10.4.3. Germany
10.4.4. Italy
10.4.5. Spain
10.4.6. Nordic
10.4.7. Benelux
10.4.8. Rest of Western Europe
10.5.Market Attractiveness Analysis
10.5.1. By Product Type
10.5.2. By End User
10.5.3. By Country
11. Eastern Europe Continuous Renal Replacement therapy Analysis and Forecast
11.1.Introduction
11.1.1. Basis Point Share (BPS) Analysis By Country
11.1.2. Y-o-Y Growth Projections By Country
11.2.Market Value Forecast By Product Type, 2017–2027
11.2.1. Dialysis System
11.2.2. Consumables
11.2.2.1. Hemofilter sets
11.2.2.2. Solution
11.2.2.3. Accessories
11.3.Market Value Forecast By End User, 2017–2027
11.3.1. Hospital
11.3.2. Dialysis Center
11.4.Market Value Forecast By Country, 2017–2027
11.4.1. Russia
11.4.2. Poland
11.4.3. Rest of Eastern Europe
11.5.Market Attractiveness Analysis
11.5.1. By Product Type
11.5.2. By End User
11.5.3. By Country
12. Asia Pacific Excluding Japan (APEJ) Continuous Renal Replacement therapy Analysis and Forecast
12.1.Introduction
12.1.1. Basis Point Share (BPS) Analysis By Country
12.1.2. Y-o-Y Growth Projections By Country
12.2.Market Value Forecast By Product Type, 2017–2027
12.2.1. Dialysis System
12.2.2. Consumables
12.2.2.1. Hemofilter sets
12.2.2.2. Solution
12.2.2.3. Accessories
12.3.Market Value Forecast By End User, 2017–2027
12.3.1. Hospital
12.3.2. Dialysis Center
12.4.Market Value Forecast By Country, 2017–2027
12.4.1. China
12.4.2. India
12.4.3. Australia & New Zealand
12.4.4. ASEAN
12.4.5. Rest of APEJ
12.5.Market Attractiveness Analysis
12.5.1. By Product Type
12.5.2. By End User
12.5.3. By Country
13. Japan Continuous Renal Replacement therapy Analysis and Forecast
13.1.Introduction
13.1.1. Basis Point Share (BPS) Analysis By Country
13.1.2. Y-o-Y Growth Projections By Country
13.2.Market Value Forecast By Product Type, 2017–2027
13.2.1. Dialysis System
13.2.2. Consumables
13.2.2.1. Hemofilter sets
13.2.2.2. Solution
13.2.2.3. Accessories
13.3.Market Value Forecast By End User, 2017–2027
13.3.1. Hospital
13.3.2. Dialysis Center
13.4.Market Attractiveness Analysis
13.4.1. By Product Type
13.4.2. By End User
14. Middle East and Africa (MEA) Continuous Renal Replacement therapy Analysis and Forecast
14.1.Introduction
14.1.1. Basis Point Share (BPS) Analysis By Country
14.1.2. Y-o-Y Growth Projections By Country
14.2.Market Value Forecast By Product Type, 2017–2027
14.2.1. Dialysis System
14.2.2. Consumables
14.2.2.1. Hemofilter sets
14.2.2.2. Solution
14.2.2.3. Accessories
14.3.Market Value Forecast By End User, 2017–2027
14.3.1. Hospital
14.3.2. Dialysis Center
14.4.Market Value Forecast By Country, 2017–2027
14.4.1. GCC Countries
14.4.2. South Africa
14.4.3. Rest of MEA
14.5.Market Attractiveness Analysis
14.5.1. By Product Type
14.5.2. By End User
14.5.3. By Country
15. Competition Landscape
15.1. Competition Dashboard
15.2. Company Profiles (Details – Overview, Financials, Strategy, Recent Developments)
15.2.1. Fresenius Medical Care AG & Co. KGaA
15.2.2. Baxter International Inc.
15.2.3. B. Braun Melsungen AG
15.2.4. Nikkiso Co., Ltd
15.2.5. NxStage Medical, Inc.
15.2.6. Asahi Kasei Corp
15.2.7. NIPRO Corporation
15.2.8. Medica spa.
15.2.9. Toray Medical Co., Ltd,
15.2.10. Medtronic plc.,
15.2.11.Bain Medical Equipment (Guangzhou) Co. Ltd.,
15.2.12. INFOMED SA.,
15.2.13. Medical Components, Inc.,
15.2.14. Medites Pharma, S.R.O.,
15.2.15.Jihua Medical Apparatus & Instruments Co.,
15.2.16.Central Admixture Pharmacy Services Inc.,
15.2.17. Haidylina for Advanced Medical Industries.
15.2.18. Hemoclean Co. Ltd.,
15.2.19. FARMASOL Medical Products Ind. and Trd. Co.,

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report